Brief: Antengene Corp Says Singapore Health Sciences Authority Approved Co's New Drug Application
01/03/2022 15:18
March 1 (Reuters) - Antengene Corporation Ltd 6996.HK :
* SINGAPORE HEALTH SCIENCES AUTHORITY APPROVED CO'S NEW DRUG
APPLICATION FOR XPOVIO (SELINEXOR)
Further company coverage: 6996.HK
Recent news on Antengene
See all newsBiotech firm Antengene's H1 revenue jumps on licensing deals
Brief: Antengene Corp Expects HY Profit Of RMB195 MLN-RMB238 MLN
Brief: Antengene Corp Receives Initial $60 Million Upfront Payment From UCB
Brief: Antengene Corp Intends To Repurchase Up To 67.92 Million Shares
Brief: Antengene Corp Enters Exclusive License Agreement With K2 Therapeutics For Atg-106